Background: Glottic insufficiency negatively affects phonation and swallowing function. Injection laryngoplasty is a convenient and minimally invasive treatment for glottic insufficiency. This study assessed whether injection laryngoplasty is safe under continued administration of antithrombotic drugs, and aimed to establish measurable laboratory values under which such a procedure can be safely performed. Method: This retrospective medical record review covered the period from November 2012 to June 2018. We examined 17 patients who underwent injection laryngoplasty (47 injections) under continued administration of antithrombotic drugs at the University of Tokyo Hospital. We analyzed clinical and demographic profiles, complications, and blood test values. Statistical analyses were performed regarding the risks of complications due to injection side, route of administration, and number of antithrombotic drugs. Results: No patients exhibited airway narrowing or dyspnea; however, bleeding after injection laryngoplasty was observed in 3 patients. All patients exhibited values within the optimal treatment range. There were no significant differences regarding the risks of complications due to injection side, route of administration, or number of antithrombotic drugs. Conclusions: When the platelet count, prothrombin time-international normalized ratio, and activated partial thromboplastin time were within the optimal range prior to treatment, injection laryngoplasty could safely be performed, regardless of the administration of antithrombotic drugs.

1.
Kraus
DH
,
Ali
MK
,
Ginsberg
RJ
,
Hughes
CJ
,
Orlikoff
RF
,
Rusch
VW
, et al
Vocal cord medialization for unilateral paralysis associated with intrathoracic malignancies
.
J Thorac Cardiovasc Surg
.
1996
Feb
;
111
(
2
):
334
9
.
[PubMed]
0022-5223
2.
Mom
T
,
Filaire
M
,
Advenier
D
,
Guichard
C
,
Naamee
A
,
Escande
G
, et al
Concomitant type I thyroplasty and thoracic operations for lung cancer: preventing respiratory complications associated with vagus or recurrent laryngeal nerve injury
.
J Thorac Cardiovasc Surg
.
2001
Apr
;
121
(
4
):
642
8
.
[PubMed]
0022-5223
3.
Mikaelian
DO
,
Lowry
LD
,
Sataloff
RT
.
Lipoinjection for unilateral vocal cord paralysis
.
Laryngoscope
.
1991
May
;
101
(
5
):
465
8
.
[PubMed]
0023-852X
4.
Hess
MM
,
Fleischer
S
.
Laryngeal framework surgery: current strategies
.
Curr Opin Otolaryngol Head Neck Surg
.
2016
Dec
;
24
(
6
):
505
9
.
[PubMed]
1068-9508
5.
Boster
SR
,
Bergin
JJ
.
Upper airway obstruction complicating warfarin therapy—with a note on reversal of warfarin toxicity
.
Ann Emerg Med
.
1983
Nov
;
12
(
11
):
711
5
.
[PubMed]
0196-0644
6.
Kerr
HD
,
Kwaselow
A
.
Vocal cord hematomas complicating anticoagulant therapy
.
Ann Emerg Med
.
1984
Jul
;
13
(
7
):
552
3
.
[PubMed]
0196-0644
7.
Laing
C
,
Kelly
J
,
Coman
S
,
Thomson
A
.
Vocal cord haematoma after thrombolysis
.
Lancet
.
1997
Dec
;
350
(
9092
):
1677
.
[PubMed]
0140-6736
8.
Scully
C
,
Wolff
A
.
Oral surgery in patients on anticoagulant therapy
.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
.
2002
Jul
;
94
(
1
):
57
64
.
[PubMed]
1079-2104
9.
Francis
DO
,
Dang
JH
,
Fritz
MA
,
Garrett
CG
.
Antiplatelet and anticoagulation therapy in microlaryngeal surgery
.
Laryngoscope
.
2014
Apr
;
124
(
4
):
928
34
.
[PubMed]
0023-852X
10.
Dang
JH
,
Liou
NE
,
Ongkasuwan
J
.
Anticoagulation and antiplatelet therapy in awake transcervical injection laryngoplasty
.
Laryngoscope
.
2017
Aug
;
127
(
8
):
1850
4
.
[PubMed]
0023-852X
11.
Ohgushi
A
,
Ohtani
T
,
Nakayama
N
,
Asai
S
,
Ishii
Y
,
Namiki
A
, et al
Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control study
.
J Pharm Health Care Sci
.
2016
Jan
;
2
(
1
):
2
.
[PubMed]
2055-0294
12.
Hirsh
J
,
Warkentin
TE
,
Raschke
R
,
Granger
C
,
Ohman
EM
,
Dalen
JE
.
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
.
Chest
.
1998
Nov
;
114
(
5
Suppl
):
489S
510S
.
[PubMed]
0012-3692
13.
Misono
S
,
Yueh
B
,
Stockness
AN
,
House
ME
,
Marmor
S
.
Minimal Important Difference in Voice Handicap Index-10
.
JAMA Otolaryngol Head Neck Surg
.
2017
Nov
;
143
(
11
):
1098
103
.
[PubMed]
2168-6181
14.
Tirado
Y
,
Lewin
JS
,
Hutcheson
KA
,
Kupferman
ME
.
Office-based injection laryngoplasty in the irradiated larynx
.
Laryngoscope
.
2010
Apr
;
120
(
4
):
703
6
.
[PubMed]
0023-852X
15.
Kaufman
RM
,
Djulbegovic
B
,
Gernsheimer
T
,
Kleinman
S
,
Tinmouth
AT
,
Capocelli
KE
, et al;
AABB
.
Platelet transfusion: a clinical practice guideline from the AABB
.
Ann Intern Med
.
2015
Feb
;
162
(
3
):
205
13
.
[PubMed]
0003-4819
16.
Burger
W
,
Chemnitius
JM
,
Kneissl
GD
,
Rücker
G
.
Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis
.
J Intern Med
.
2005
May
;
257
(
5
):
399
414
.
[PubMed]
0954-6820
17.
Wilson
SH
,
Fasseas
P
,
Orford
JL
,
Lennon
RJ
,
Horlocker
T
,
Charnoff
NE
, et al
Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting
.
J Am Coll Cardiol
.
2003
Jul
;
42
(
2
):
234
40
.
[PubMed]
0735-1097
18.
Kimura
M
,
Nito
T
,
Imagawa
H
,
Tayama
N
.
Treatment of vocal fold paralysis by collagen injection: long-term results
.
J Jpn Bronchoesophagol Soc.
2008
Jun
;
59
(
3
):
304
10
.
19.
Yokoyama
T
,
Yamashita
K
,
Yamasaki
F
,
Ueta
T
,
Manabe
M
,
Nishiyama
T
.
Aspirin reversal—an incremental administration of aspirin shortens the bleeding time prolonged by low-dose aspirin
.
Masui
.
2003
Apr
;
52
(
4
):
399
401
.
[PubMed]
0021-4892
20.
Chandran
D
,
Woods
C
,
Ullah
S
,
Ooi
E
,
Athanasiadis
T
.
A comparative study of voice outcomes and complication rates in patients undergoing injection laryngoplasty performed under local versus general anaesthesia: an Adelaide voice specialist’s experience
.
J Laryngol Otol
.
2017
Jan
;
131
S1
:
S41
6
.
[PubMed]
0022-2151
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.